Cone Beam Computed Tomography for Breast Imaging



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:11/18/2012
Start Date:June 2008
End Date:May 2013
Contact:Posy Seifert, D.O.
Email:pseifert@ewbc.com
Phone:585-442-8029

Use our guide to learn which trials are right for you!

Cone Beam Computed Tomography for Breast Imaging and IV Contrast Enhanced Cone Beam Computed Tomography Breast Imaging


The primary aim of this study is to investigate the use of cone beam computed tomography
(CBCT) for breast imaging in the diagnostic setting by providing a compelling body of
evidence incorporating both non-contrast and contrast enhanced CBCT in the study protocol.
The goal is to accumulate a body of evidence to provide data to incorporate CBCT into the
diagnostic work-up of breast lesions.


Inclusion Criteria:

Group I:

- Are at least 40 years of age of any ethnicity

- Had a mammogram, read as BI-RADS® 1 or 2

- Will undergo study imaging no later than four weeks from date of mammogram.

- Is able to undergo informed consent.

Group II:

- Are at least 40 years of age of any ethnicity

- Had a routine mammogram, read as BI-RADS® 4 or 5

- Are scheduled for breast biopsy

- Will undergo study imaging no later than four weeks from date of mammogram, prior to
breast biopsy.

- Is able to undergo informed consent.

Group III:

- Are at least 40 years of age of any ethnicity

- Had a routine mammogram, read as BI-RADS® 4 or 5

- Are scheduled for breast biopsy

- Will undergo study imaging no later than four weeks from date of mammogram, prior to
breast biopsy.

- Is able to undergo informed consent.

Exclusion Criteria:

Group I and Group II:

- Pregnancy

- Lactation

- Subjects with physical limitations that may prohibit resting prone on the exam table,
such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.

- Subjects who are unable to tolerate study constraints.

- Subjects who have received radiation treatments to the thorax for malignant and
nonmalignant conditions, such as (but not limited to)

- Treatment for enlarged thymus gland as an infant

- Irradiation for benign breast conditions, including breast inflammation after
giving birth

- Treatment for Hodgkins disease

- Subjects who have participated in a prior breast clinical trial that gave additional
radiation dose, such as an additional mammogram.

- Subjects who have received large numbers of diagnostic x-ray examinations for
monitoring of disease such as (but not limited to)

- Tuberculosis

- Severe scoliosis

Group III:

- Pregnancy

- Lactation

- Subjects with physical limitations that may prohibit resting prone on the exam table,
such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.

- Subjects who are unable to tolerate study constraints.

- Subjects who have received radiation treatments to the thorax for malignant and
nonmalignant conditions, such as (but not limited to)

- Treatment for enlarged thymus gland as an infant

- Irradiation for benign breast conditions, including breast inflammation after
giving birth

- Treatment for Hodgkins disease

- Subjects who have participated in a prior breast clinical trial that gave additional
radiation dose, such as an additional mammogram.

- Subjects who have received large numbers of diagnostic x-ray examinations for
monitoring of disease such as (but not limited to)

- Tuberculosis

- Severe scoliosis

- Allergy or previous reaction to iodinated contrast material

- History of renal dysfunction/kidney disease

- Long standing diabetes mellitus

- Multiple myeloma

- Dehydration

- History of nephrotoxic medication use

- Hyperthyroidism

- Diabetic patients on Metformin

- Pheochromocytoma

- Sickle Cell Disease
We found this trial at
1
site
Rochester, New York 14620
?
mi
from
Rochester, NY
Click here to add this to my saved trials